Daxin Pang Selected Research

Daxin Pang Research Topics

Disease

6	Cardiovascular Diseases (Cardiovascular Disease) 01/2018 - 04/2015
4	Neoplasms (Cancer) 01/2022 - 01/2016
4	Inflammation (Inflammations) 11/2018 - 04/2015
3	Infections 11/2019 - 01/2017
2	Virus Diseases (Viral Diseases) 01/2022 - 01/2016
2	Hypertriglyceridemia 06/2019 - 01/2012
2	Classical Swine Fever (Swine Fever) 01/2019 - 03/2011
2	Atherosclerosis 01/2019 - 01/2018
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2022
1	Melanoma (Melanoma, Malignant) 01/2022
1	Muscular Dystrophies (Muscular Dystrophy) 12/2021
1	Hypertrophy 12/2021
1	Malnutrition (Nutritional Deficiencies) 07/2021
1	Hemophilia B (Haemophilia B) 01/2021
1	Hemorrhage 01/2021
1	Cachexia 06/2019
1	Colonic Neoplasms (Colon Cancer) 06/2019
1	Hyperlipidemias (Hyperlipidemia) 06/2019
1	Dyslipidemias (Dyslipidemia) 06/2019
1	Atherosclerotic Plaque (Atheroma) 01/2019
1	Wounds and Injuries (Trauma) 11/2018
1	Marfan Syndrome (Marfan's Syndrome) 01/2018
1	Myocarditis (Carditis) 01/2018
1	Lipodystrophy 01/2018
1	Heart Failure 01/2018
1	Hypertension (High Blood Pressure) 01/2018
1	Alzheimer Disease (Alzheimer's Disease) 11/2016
1	Parkinson Disease (Parkinson's Disease) 11/2016
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2016
1	Urinary Bladder Neoplasms (Bladder Cancer) 01/2016
1	Squamous Cell Carcinoma of Head and Neck 01/2016
1	Vascular Diseases (Vascular Disease) 09/2015
1	Spontaneous Abortion (Miscarriage) 05/2014
1	Coronary Disease (Coronary Heart Disease) 01/2012
1	Asthma (Bronchial Asthma) 09/2011
1	Breast Neoplasms (Breast Cancer) 08/2011

Drug/Important Bio-Agent (IBA)

5	Proteins (Proteins, Gene)FDA Link 11/2019 - 09/2015
4	1-Alkyl-2-acetylglycerophosphocholine Esterase (PAF Acetylhydrolase)IBA 10/2017 - 04/2015
3	Triglycerides (Triacylglycerol)IBA 06/2019 - 01/2012
2	MicroRNAs (MicroRNA)IBA 11/2018 - 01/2018
2	LipopolysaccharidesIBA 11/2018 - 10/2017
1	Telomerase (Telomerase Reverse Transcriptase)IBA 01/2022
1	Amino Acids FDA Link 01/2022
1	Antiviral Agents (Antivirals)IBA 01/2022
1	BESIBA 01/2022
1	Heat-Shock Proteins (Heat-Shock Protein)IBA 01/2022
1	FollistatinIBA 12/2021
1	Myogenic Regulatory FactorsIBA 12/2021
1	MyostatinIBA 12/2021
1	DystrophinIBA 07/2021
1	Factor IX (Coagulation Factor IX)FDA LinkGeneric 01/2021
1	Viral ProteinsIBA 11/2019
1	Coenzyme A (CoA)IBA 11/2019
1	AMP-Activated Protein KinasesIBA 11/2019
1	Protein Phosphatase 2 (Protein Phosphatase 2A)IBA 11/2019
1	Oxidoreductases (Dehydrogenase)IBA 11/2019
1	Adenosine (Adenocard)FDA LinkGeneric 11/2019
1	high density lipoprotein binding proteinIBA 06/2019
1	Lipoprotein Lipase (Diacylglycerol Lipase)IBA 06/2019
1	Messenger RNA (mRNA)IBA 06/2019
1	Glycosylphosphatidylinositols (Glycosyl-Phosphatidylinositol)IBA 06/2019
1	CyclodextrinsIBA 01/2019
1	HDL CholesterolIBA 01/2019
1	LipidsIBA 01/2019
1	Small Interfering RNA (siRNA)IBA 01/2019
1	Therapeutic UsesIBA 01/2019
1	CytokinesIBA 01/2019
1	Phosphotransferases (Kinase)IBA 11/2018
1	Fibrillin-1IBA 01/2018
1	Contractile ProteinsIBA 01/2018
1	ResveratrolIBA 10/2017
1	superoxide dismutase 2IBA 10/2017
1	AntioxidantsIBA 10/2017
1	Reactive Oxygen Species (Oxygen Radicals)IBA 10/2017
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 10/2017
1	OligonucleotidesIBA 11/2016
1	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 05/2016
1	Biological ProductsIBA 01/2016
1	tdTomatoIBA 01/2016
1	DNA (Deoxyribonucleic Acid)IBA 01/2016
1	CateninsIBA 01/2016
1	Fatty Acids (Saturated Fatty Acids)IBA 09/2015
1	Docosahexaenoic AcidsIBA 09/2015
1	Glycerol (Glycerine)FDA LinkGeneric 04/2015
1	Biomarkers (Surrogate Marker)IBA 04/2015
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 05/2014
1	AngiopoietinsIBA 05/2014
1	ApolipoproteinsIBA 01/2012
1	Lipoproteins (Lipoprotein)IBA 01/2012
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 09/2011
1	Mitogen-Activated Protein KinasesIBA 09/2011
1	ginkgolide BIBA 09/2011
1	Platelet Activating FactorIBA 09/2011
1	Fibroblast Growth Factor 1 (FGF-1)IBA 08/2011
1	RNA (Ribonucleic Acid)IBA 03/2011

Therapy/Procedure

2	Therapeutics 01/2021 - 01/2019